Abbott Laboratories has successfully obtained an injunction against a number of US retailers selling ‘grey good’ strips for diabetics that had been manufactured in Ireland and later sold in the US at a lower price.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Abbott Laboratories; US District Court for the Eastern District of New York; grey goods; Freestyle; diabetes; trademarks